Official ESCRS | European Society of Cataract & Refractive Surgeons
London 2014 Registration Visa Letters Programme Satellite Meetings Glaucoma Day 2014 Exhibition Hotel Booking Virtual Exhibition Star Alliance
london escrs

Course handouts are now available
Click here

Come to London


WATCH to find out why

Site updates:

Programme Updates. Programme Overview and - Video Symposium on Challenging Cases now available.


Search Abstracts by author or title
(results will display both Free Papers & Poster)

Clinical outcome after retreamtent in PresbyMAX for simultaneous correction of presbyopia and ametropia in 15 patients

Poster Details

First Author: D.Holland GERMANY

Co Author(s):    M. Poelz   T. Herbst   D. Uthoff        

Abstract Details


The treatment of Presbyopia is still one of the greatest challenges in ophthalmology. Apart from MIOL implantation monovision or Presbylasik with the excimer laser is an alternative option. Like in all refractive procedures in Presbylasik refractive surprises are possible. We investigated the outcomes in patients who underwent retreatments after simultaneous correction of presbyopia and ametropia by biaspherical Presby-Lasik technique based on the creation of a central area hyperpositive for near vision and leaving the midperipheral cornea for far vision with a concept called PresbyMax® on the Schwind Amaris plattform.


Augenklinik Bellevue in Kiel/Germany.


15 patients of 86 presbyopic patients underwent Re-Lasik due to insufficient refractive and visual outcome. Mean patient age was 52.0 years. Due to refractive changes and neuroadaptation re treatments were performed not before 6 months after the primary treatment. In most patients over correction and insufficient UCDVA was the reason for re treatment. No patient received a reversal due to intolerance to Presbylasik.


No patient received more than one retreatment. 15 patients were retreated monolateraly and one patient bilateraly. Mean refraction changed from -0.78 dpt before re treatment to -0.38dpt. Binocular DUCVA and NUCVA was 0.05 LogMar/LogRad. Due to relatively high patient age and the re lift and additional laser treatment dry eye symptoms appeared in nearly all patients.


In presbyopic patients without symptomatic cataract, but refractive errors PresbyMAX will decrease the presbyopic symptoms and correct far-distance refraction in the same treatment offering spectacle-free vision in daily life in most of the treated patients even if a re treatment is necessary.

Financial Disclosure:


Back to Poster listing